| # | Drug | Count |
|---|---|---|
| 0 | FUROSEMIDE | 15 |
| 1 | PREDNISOLONE | 12 |
| 2 | PREDNISOLONE ORAL | 12 |
| 3 | PREDNISOLONE ORAL SOLUTION | 12 |
| 4 | APIXABAN | 8 |
| 5 | SPIRONOLACTONE | 8 |
| 6 | RISPERIDONE | 7 |
| 7 | LANSOPRAZOLE | 6 |
| 8 | MAGNESIUM OXIDE | 6 |
| 9 | AMLODIPINE | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SOYBEAN OIL | 1 | 0.0015 |
| 1 | ESTAZOLAM | 2 | 0.0010 |
| 2 | DANTROLENE SODIUM | 1 | 0.0009 |
| 3 | FLURBIPROFEN | 1 | 0.0007 |
| 4 | CASPOFUNGIN ACETATE | 1 | 0.0006 |
| 5 | DEFEROXAMINE MESYLATE | 1 | 0.0005 |
| 6 | SALINE NASAL SPRAY | 2 | 0.0005 |
| 7 | PITAVASTATIN CALCIUM | 4 | 0.0004 |
| 8 | GLYCERIN SUPPOSITORY | 1 | 0.0004 |
| 9 | GLYCERIN SUPPOSITORIES | 1 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Loop Diuretic [EPC] | 15 |
| 1 | Corticosteroid [EPC] | 13 |
| 2 | Atypical Antipsychotic [EPC] | 11 |
| 3 | Factor Xa Inhibitor [EPC] | 10 |
| 4 | Proton Pump Inhibitor [EPC] | 10 |
| 5 | Aldosterone Antagonist [EPC] | 8 |
| 6 | Dihydropyridine Calcium Channel Blocker [EPC] | 7 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 7 |
| 8 | Benzodiazepine [EPC] | 6 |
| 9 | Calcium Channel Blocker [EPC] | 5 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lipid Emulsion [EPC] | 1 | 0.0004 |
| 1 | Chloride Channel Activator [EPC] | 2 | 0.0002 |
| 2 | Vasopressin V2 Receptor Antagonist [EPC] | 3 | 0.0002 |
| 3 | Osmotic Diuretic [EPC] | 1 | 0.0002 |
| 4 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 5 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 6 | Melatonin Receptor Agonist [EPC] | 2 | 0.0002 |
| 7 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 1 | 0.0001 |
| 8 | Cephalosporin Antibacterial [EPC] | 1 | 0.0001 |
| 9 | Orexin Receptor Antagonist [EPC] | 2 | 0.0001 |